Finale Doshi-Velez1, Yaorong Ge, Isaac Kohane. 1. Center for Biomedical Informatics, Harvard Medical School, 10 Shattuck St, Boston, MA 02115. finale_doshi-velez@hms.harvard.edu.
Abstract
OBJECTIVE: The distinct trajectories of patients with autism spectrum disorders (ASDs) have not been extensively studied, particularly regarding clinical manifestations beyond the neurobehavioral criteria from the Diagnostic and Statistical Manual of Mental Disorders. The objective of this study was to investigate the patterns of co-occurrence of medical comorbidities in ASDs. METHODS: International Classification of Diseases, Ninth Revision codes from patients aged at least 15 years and a diagnosis of ASD were obtained from electronic medical records. These codes were aggregated by using phenotype-wide association studies categories and processed into 1350-dimensional vectors describing the counts of the most common categories in 6-month blocks between the ages of 0 to 15. Hierarchical clustering was used to identify subgroups with distinct courses. RESULTS: Four subgroups were identified. The first was characterized by seizures (n = 120, subgroup prevalence 77.5%). The second (n = 197) was characterized by multisystem disorders including gastrointestinal disorders (prevalence 24.3%) and auditory disorders and infections (prevalence 87.8%), and the third was characterized by psychiatric disorders (n = 212, prevalence 33.0%). The last group (n = 4316) could not be further resolved. The prevalence of psychiatric disorders was uncorrelated with seizure activity (P = .17), but a significant correlation existed between gastrointestinal disorders and seizures (P < .001). The correlation results were replicated by using a second sample of 496 individuals from a different geographic region. CONCLUSIONS: Three distinct patterns of medical trajectories were identified by unsupervised clustering of electronic health record diagnoses. These may point to distinct etiologies with different genetic and environmental contributions. Additional clinical and molecular characterizations will be required to further delineate these subgroups.
OBJECTIVE: The distinct trajectories of patients with autism spectrum disorders (ASDs) have not been extensively studied, particularly regarding clinical manifestations beyond the neurobehavioral criteria from the Diagnostic and Statistical Manual of Mental Disorders. The objective of this study was to investigate the patterns of co-occurrence of medical comorbidities in ASDs. METHODS: International Classification of Diseases, Ninth Revision codes from patients aged at least 15 years and a diagnosis of ASD were obtained from electronic medical records. These codes were aggregated by using phenotype-wide association studies categories and processed into 1350-dimensional vectors describing the counts of the most common categories in 6-month blocks between the ages of 0 to 15. Hierarchical clustering was used to identify subgroups with distinct courses. RESULTS: Four subgroups were identified. The first was characterized by seizures (n = 120, subgroup prevalence 77.5%). The second (n = 197) was characterized by multisystem disorders including gastrointestinal disorders (prevalence 24.3%) and auditory disorders and infections (prevalence 87.8%), and the third was characterized by psychiatric disorders (n = 212, prevalence 33.0%). The last group (n = 4316) could not be further resolved. The prevalence of psychiatric disorders was uncorrelated with seizure activity (P = .17), but a significant correlation existed between gastrointestinal disorders and seizures (P < .001). The correlation results were replicated by using a second sample of 496 individuals from a different geographic region. CONCLUSIONS: Three distinct patterns of medical trajectories were identified by unsupervised clustering of electronic health record diagnoses. These may point to distinct etiologies with different genetic and environmental contributions. Additional clinical and molecular characterizations will be required to further delineate these subgroups.
Authors: Stephen W Porges; Matthew Macellaio; Shannon D Stanfill; Kimberly McCue; Gregory F Lewis; Emily R Harden; Mika Handelman; John Denver; Olga V Bazhenova; Keri J Heilman Journal: Int J Psychophysiol Date: 2012-11-29 Impact factor: 2.997
Authors: Li Liu; Aniko Sabo; Benjamin M Neale; Uma Nagaswamy; Christine Stevens; Elaine Lim; Corneliu A Bodea; Donna Muzny; Jeffrey G Reid; Eric Banks; Hillary Coon; Mark Depristo; Huyen Dinh; Tim Fennel; Jason Flannick; Stacey Gabriel; Kiran Garimella; Shannon Gross; Alicia Hawes; Lora Lewis; Vladimir Makarov; Jared Maguire; Irene Newsham; Ryan Poplin; Stephan Ripke; Khalid Shakir; Kaitlin E Samocha; Yuanqing Wu; Eric Boerwinkle; Joseph D Buxbaum; Edwin H Cook; Bernie Devlin; Gerard D Schellenberg; James S Sutcliffe; Mark J Daly; Richard A Gibbs; Kathryn Roeder Journal: PLoS Genet Date: 2013-04-11 Impact factor: 5.917
Authors: Tyler L Perfitt; Philip E Stauffer; Keeley L Spiess; Roger J Colbran Journal: Biochem Biophys Res Commun Date: 2020-01-23 Impact factor: 3.575
Authors: Mary Regina Boland; Zachary Shahn; David Madigan; George Hripcsak; Nicholas P Tatonetti Journal: J Am Med Inform Assoc Date: 2015-06-02 Impact factor: 4.497
Authors: Isotta Landi; Benjamin S Glicksberg; Hao-Chih Lee; Sarah Cherng; Giulia Landi; Matteo Danieletto; Joel T Dudley; Cesare Furlanello; Riccardo Miotto Journal: NPJ Digit Med Date: 2020-07-17
Authors: Xinzhi Zhang; Eliseo J Pérez-Stable; Philip E Bourne; Emmanuel Peprah; O Kenrik Duru; Nancy Breen; David Berrigan; Fred Wood; James S Jackson; David W S Wong; Joshua Denny Journal: Ethn Dis Date: 2017-04-20 Impact factor: 1.847
Authors: Molin Wang; Donna Spiegelman; Aya Kuchiba; Paul Lochhead; Sehee Kim; Andrew T Chan; Elizabeth M Poole; Rulla Tamimi; Shelley S Tworoger; Edward Giovannucci; Bernard Rosner; Shuji Ogino Journal: Stat Med Date: 2015-12-01 Impact factor: 2.373